Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Testing the association between patient safety indicators and hospital structural characteristics in VA and nonfederal hospitals.
The safety of rosiglitazone in the treatment of type 2 diabetes.
See All 2 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The safety of rosiglitazone in the treatment of type 2 diabetes.
Singh S, Loke YK. The safety of rosiglitazone in the treatment of type 2 diabetes. Expert Opin Drug Saf. 2008 Sep; 7(5):579-85.
View in:
PubMed
subject areas
Blood Glucose
Cardiovascular Diseases
Clinical Trials as Topic
Diabetes Mellitus, Type 2
Fractures, Bone
Heart Failure
Humans
Hypoglycemic Agents
Myocardial Infarction
Risk Factors
Thiazolidinediones
authors with profiles
Sonal Singh MD, MPH